Skip to content
healthcare.dev
Get a free key

TADALAFIL

NDC 76420-546, TADALAFIL, tablet, from Asclemed USA, Inc..

Product NDC
76420-546
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211839
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-546 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TADALAFIL5 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
76420-546-307642005463030 TABLET in 1 BOTTLE (76420-546-30)
76420-546-607642005466060 TABLET in 1 BOTTLE (76420-546-60)
76420-546-907642005469090 TABLET in 1 BOTTLE (76420-546-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/101f44e4-669c-4e3d-843a-a27157750f9c

Use it

Look up 76420-546 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-546 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-546. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.